Peripheral stem cell apheresis in multiple myeloma in the era of new agents

被引：0
|
作者：
Bakanay, S. M. [1 ]
Ayyildiz, E. [1 ]
Arat, M. [1 ]
Topcuoglu, P. [1 ]
Soydan, E. [1 ]
Dalva, K. [1 ]
Bozdag, S. C. [1 ]
Demir, F. [1 ]
Demirer, T. [1 ]
Arslan, O. [1 ]
Ozcan, M. [1 ]
Gurman, G. [1 ]
Beksac, M. [1 ]
Ilhan, O. [1 ]
机构：
[1] Univ Med Sch, Ankara, Turkey
来源：
BONE MARROW TRANSPLANTATION | 2011年 / 46卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：S261 / S262
页数：2
相关论文
共 50 条
  • [1] Autologous Stem Cell Transplantation for Multiple Myeloma in the Era of Novel Agents
    Shimazaki, Chihiro
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2014, 14 (01): : 14 - 15
  • [2] Effects of peripheral blood stem cell apheresis on systemic cytokine levels in patients with multiple myeloma
    Akkok, Cigdem Akalin
    Hervig, Tor
    Stamnesfet, Siren
    Nesthus, Ingerid
    Melve, Guro K.
    Lassalle, Philippe
    Bruserud, Oystein
    CYTOTHERAPY, 2011, 13 (10) : 1259 - 1268
  • [3] Depth of Response with Stem Cell Transplantation and Outcome for Multiple Myeloma in the Era of Novel Agents
    Dingli, David
    Gay, Francesca
    Buadi, Francis
    Dispenzieri, Angela
    Hayman, Suzanne R.
    Kumar, Shaji
    Lacy, Martha Q.
    Russell, Stephen J.
    Rajkumar, Vincent
    Gertz, Morie
    BLOOD, 2009, 114 (22) : 506 - 506
  • [4] New Era in Multiple Myeloma: Consequences of the Arrival of New Agents
    Sobejano, Eduardo
    Gonzalez, Veronica
    Higuero, Victor
    Garcia-Sanz, Ramon
    Presa, Daniel
    Azibeiro, Raul
    Fonseca, Marta
    Rey, Beatriz
    Puig, Noemi
    Gutierrez, Norma
    Leoz, Pilar
    Labrador, Jorge
    Aguilera, Carmen
    Escalante, Fernando
    Maria Alonso, Jose
    Lopez, Rosa
    Garcia Mateo, Aranzazu
    Garcia de Coca, Alfonso
    Hernandez, Roberto
    Barez, Abelardo
    Davila, Julio
    Redondo, Elena
    Victoria Mateos, Maria
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 : S334 - S335
  • [5] Cost effective utilization of apheresis for stem cell transplantation in multiple myeloma
    Devarakonda, Srinivas S.
    Vaishnav, Arti
    Zhao, Qiuhong
    Bumma, Naresh
    Cottini, Francesca
    Sharma, Nidhi
    Umyarova, Elvira
    Rosko, Ashley Elizabeth
    Benson, Don M., Jr.
    Khan, Abdullah Mohammad
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [6] Is There an Optimal Timing of Autologous Stem-Cell Transplantation for Multiple Myeloma in the Era of Novel Agents?
    Toprak, Selami Kocak
    TURKISH JOURNAL OF HEMATOLOGY, 2013, 30 (03) : 338 - 339
  • [7] Role Of Double Stem Cell Transplantation For Newly Diagnosed Multiple Myeloma In The Era Of Novel Agents
    Hagiwara, Shotaro
    Hirai, Risen
    Nakamura, Miki
    Tanimura, Akira
    Takeshita, Masataka
    Miwa, Akiyoshi
    BLOOD, 2013, 122 (21)
  • [8] NEW ERA IN MULTIPLE MYELOMA. CONSEQUENCES OF THE ARRIVAL OF NEW AGENTS
    Sobejano Fuertes, E.
    Gonzalez, V
    Higuero, V
    Garcia-Sanz, R.
    Presa, D.
    Azibeiro, R.
    Fonseca, M.
    Rey, B.
    Puig, N.
    Gutierrez, N.
    Leoz, P.
    Labrador, J.
    Aguilera, C.
    Escalante, F.
    Alonso Jose, M.
    Lopez, R.
    Garcia-Mateo, A.
    Garcia de Coca, A.
    Hernandez, R.
    Barez, A.
    Redondo, E.
    Mateos, M., V
    HAEMATOLOGICA, 2019, 104 : 20 - 21
  • [9] Prognostic Impact of Hyperdiploidy on Multiple Myeloma in the Era of New Agents
    Wang, Yi
    Zhuang, Jing
    An, Gang
    Mao, Xue-Han
    Du, Chenxing
    Liu, Jiahui
    Fan, Huishou
    Deng, Shuhui
    Xu, Yan
    Sui, Weiwei
    Qiu, Lugui
    BLOOD, 2020, 136
  • [10] Parthenolide and structurally related natural products as anti-cancer stem cell agents: A new era in treatment of multiple myeloma
    Huynh, Daniel T.
    Lannotti, Michael J.
    Gunn, Ellen J.
    Han, C.
    Barrios, F. J.
    Colby, David A.
    Kirshner, Julia
    CANCER RESEARCH, 2010, 70
12345